In August 2024, Novo Nordisk, one of the pharmaceutical leaders in diabetes and obesity care, launched its weight-loss drug Wegovy in Australia, intended for chronic weight management in patients with obesity or overweight with related conditions like diabetes or hypertension, Wegovy entered the market amid ongoing Ozempic supply concerns
In the January hearing, Judge Orrick found that the plaintiffs had sufficiently addressed his prior concerns, including identifying the types of medical data Meta allegedly collected
Aim to optimize exercise, nutrition, and sleep Those three things probably have the biggest impact on your physical health
Users exploring gut-supportive peptides may also benefit from the peptide stack calculator for planning multi-compound protocols, and those curious about injection methods can reference the GLP-1 injection guide and injection site guide
(8 minutes) I knew my legs were larger than they should be